{"id":{"repo_id":"columbus-state","oai_identifier":"oai:csuepress.columbusstate.edu:theses_dissertations-1340"},"canonical_url":"https://search.dev.ndltd.org/etd/columbus-state/oai:csuepress.columbusstate.edu:theses_dissertations-1340","repository":{"repo_id":"columbus-state","name":"Columbus State University","base_url":"https://csuepress.columbusstate.edu/do/oai/"},"display":{"title":"Correlation of Aqueous Solubility and Anti-Cancer Activity of Novel Triazolium and Imidazolium Salts","abstract":"<p>Novel triazolium, imidazolium, and benzimidazolium salts are known to possess anti-cancer properties and have potential as cancer therapeutics. This thesis describes the aqueous solubility and the differential activity of N,AT-bis-substituted-l,2,4-triazolium bromide salts and N/N'-bis(naphthylmethyl)imidazolium bromide salts against MDA-MB-468 breast cancer cells and PC-3 prostate carcinomas. Using a microscale technique, the partition coefficient (log P) of each salt was determined. The log P value was explored to determine the bioavailability of each derivative.</p>","abstract_html":"&lt;p&gt;Novel triazolium, imidazolium, and benzimidazolium salts are known to possess anti-cancer properties and have potential as cancer therapeutics. This thesis describes the aqueous solubility and the differential activity of N,AT-bis-substituted-l,2,4-triazolium bromide salts and N/N&#x27;-bis(naphthylmethyl)imidazolium bromide salts against MDA-MB-468 breast cancer cells and PC-3 prostate carcinomas. Using a microscale technique, the partition coefficient (log P) of each salt was determined. The log P value was explored to determine the bioavailability of each derivative.&lt;/p&gt;","abstract_has_math":false,"creators":["Bies, Jared J."],"institution":null,"degree_name":"Chemistry","degree_level":"Thesis","degree_discipline":"Chemistry","degree_department":null,"school":null,"contributors":["Dr. Jonathan Meyers","Dr. Kerri Taylor","Dr. Cindy Ticknor"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2018,"date_issued":"2018-01-01T08:00:00Z","date_published":"2018-01-01T08:00:00Z","updated_at":"2026-07-24T01:45:01Z","subjects":["Aqueous Solubility","Anti-Cancer","Novel Triazolium Salts","Imidazolium Salts","Cancer Therapeutics","Benzimidazolium Salts","Chemistry","Medicinal-Pharmaceutical Chemistry"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"https://csuepress.columbusstate.edu/theses_dissertations/338","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Dr. Jonathan Meyers","Dr. Kerri Taylor","Dr. Cindy Ticknor"]},{"key":"dc:creator","label":"Author","values":["Bies, Jared J."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2020-01-23T08:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemistry"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Thesis"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Chemistry"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Aqueous Solubility","Anti-Cancer","Novel Triazolium Salts","Imidazolium Salts","Cancer Therapeutics","Benzimidazolium Salts","Chemistry","Medicinal-Pharmaceutical Chemistry"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://csuepress.columbusstate.edu/theses_dissertations/338"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["<p>Novel triazolium, imidazolium, and benzimidazolium salts are known to possess anti-cancer properties and have potential as cancer therapeutics. This thesis describes the aqueous solubility and the differential activity of N,AT-bis-substituted-l,2,4-triazolium bromide salts and N/N'-bis(naphthylmethyl)imidazolium bromide salts against MDA-MB-468 breast cancer cells and PC-3 prostate carcinomas. Using a microscale technique, the partition coefficient (log P) of each salt was determined. The log P value was explored to determine the bioavailability of each derivative.</p>"]},{"key":"dc:title","label":"Title","values":["Correlation of Aqueous Solubility and Anti-Cancer Activity of Novel Triazolium and Imidazolium Salts"]}]}],"canonical_facts":{"dc:contributor":["Dr. Jonathan Meyers","Dr. Kerri Taylor","Dr. Cindy Ticknor"],"dc:creator":["Bies, Jared J."],"dc:date.available":["2020-01-23T08:00:00Z"],"dc:description.abstract":["<p>Novel triazolium, imidazolium, and benzimidazolium salts are known to possess anti-cancer properties and have potential as cancer therapeutics. This thesis describes the aqueous solubility and the differential activity of N,AT-bis-substituted-l,2,4-triazolium bromide salts and N/N'-bis(naphthylmethyl)imidazolium bromide salts against MDA-MB-468 breast cancer cells and PC-3 prostate carcinomas. Using a microscale technique, the partition coefficient (log P) of each salt was determined. The log P value was explored to determine the bioavailability of each derivative.</p>"],"dc:identifier":["https://csuepress.columbusstate.edu/theses_dissertations/338"],"dc:language":["English"],"dc:subject":["Aqueous Solubility","Anti-Cancer","Novel Triazolium Salts","Imidazolium Salts","Cancer Therapeutics","Benzimidazolium Salts","Chemistry","Medicinal-Pharmaceutical Chemistry"],"dc:title":["Correlation of Aqueous Solubility and Anti-Cancer Activity of Novel Triazolium and Imidazolium Salts"],"thesis:degree_discipline":["Chemistry"],"thesis:degree_level":["Thesis"],"thesis:degree_name":["Chemistry"]},"updated_at":"2026-07-24T01:45:01Z"}